𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Blood–brain barrier and drug delivery in central nervous system tumors

✍ Scribed by Clark Watts

Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
125 KB
Volume
21
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Capillary physiology and drug delivery i
Capillary physiology and drug delivery in central nervous system lymphomas
✍ Peter C. Warnke; Jens Timmer; Christoph B. Ostertag; Klaus Kopitzki 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB

## Abstract To evaluate whether the chemosensitivity of primary central nervous system lymphomas to water‐soluble drugs could result from improved drug delivery, we quantitatively assessed pharmacokinetic factors in seven patients. The capillary permeability surface product was found to be signific

GDNF fusion protein for targeted-drug de
GDNF fusion protein for targeted-drug delivery across the human blood–brain barrier
✍ Ruben J. Boado; Yun Zhang; Yufeng Zhang; Yuntao Wang; William M. Pardridge 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB

## Abstract Glial‐derived neurotrophic factor (GDNF) is a neurotrophin that could be developed as a neurotherapeutic for Parkinson's disease, stroke, and motor neuron disease. However, GDNF does not cross the blood–brain barrier (BBB). Human GDNF was re‐engineered by fusion of the mature GDNF prote

Radiotherapy of central nervous system t
Radiotherapy of central nervous system tumors in young children: Benefits and pitfalls
✍ Skowro?ska-Gardas, Anna 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 2 views

Background. The prognosis for young children suffering from brain tumors is, as many authors report, generally poor. The probability of late complications in young children is also high, and their quality of life is significantly worse than that of older children. This study presents the experience

Mutation analysis and loss of heterozygo
Mutation analysis and loss of heterozygosity of PEDF in central nervous system primitive neuroectodermal tumors
✍ Irene Slavc; Ignacio R. Rodriguez; Krzysztof Mazuruk; Gerald J. Chader; Jaclyn A 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 120 KB 👁 1 views

Deletion of 17p is the most frequent abnormality observed in central nervous system (CNS) primitive neuroectodermal tumors (PNETs), implicating the presence of a tumor suppressor gene which maps to 17p. The gene for pigment epitheliumderived factor (PEDF) has been cloned and mapped to 17p13. PEDF be